atherosclerosis
DESCRIPTION
Atherosclerosis. Caitlin Cleary Biochemistry Spring ‘12. What is it?. A type of arteriosclerosis characterized by changes in the endothelial lining and the formation of a plaque Occurs in people whose blood contains elevated levels of plasma lipids, such as cholesterol - PowerPoint PPT PresentationTRANSCRIPT
AtherosclerosisCaitlin Cleary
Biochemistry Spring ‘12
What is it?A type of arteriosclerosis characterized by
changes in the endothelial lining and the formation of a plaque
Occurs in people whose blood contains elevated levels of plasma lipids, such as cholesterol
Causes chest pain, heart attack, and strokeCan lead to coronary artery disease
How does it occur?
InflammationPromotes initiation and development of
atherosclerosis, and therefore contributes to fast forming acute blood clots
Inflammation can be triggered by:InfectionObesityHypertension
Who is at risk?Everyone!By the time young adults reach their 30s,
some degree of atherosclerosis has developed in 80 to 90% of people in the united states
Nearly 50% of the US population has elevated LDL cholesterol
PreventionStart monitoring for risk factors in
adolescentsFasting Lipid ProfileEvaluate for hypertensionScreen for diabetesScreen for metabolic syndrome
Therapeutic Lifestyle ChangesDietPhysical activityCessation of smoking
Current TreatmentsDietary supplements and herbal preparations
are questionableLDL Cholesterol-Lowering Therapies
StatinsEzetimibeEicosapentaenoic acid from Fish OilNiacin
Future Treatment?Oral Anit-CD3 Antibody Treatment Study
Treated mice with 5 microgram dosage of anti-CD3 antibody for 5 days 50% reduction in lesion formation 38% reduction in accumulation of macrophages 30% decrease in T-cell infiltration
Works CitedCampbell, Mary K., & Farrell, Shawn O. (2012). Biochemistry.
Belmont, CA: Brooks/Cole.Lewis, Sandra J. (2009). Prevention and Treatment of
Atherosclerosis: A Practitioner’s Guide for 2008. The American Journal of Medicine, 122(1A), 38-50.
Libby, Peter., Ridker, Paul M., & Maseri, Attilio. (2002). Inflammation and Atherosclerosis. Journal of the American Heart Association, 105, 1135-1143.
Sasaki, Naoto., Yamashita, Tomoya., Takeda, Masafumi., Shinohara, Masakazu., Nakajima, Kenji., Tawa, Hideto., et al. (2009). Oral Anti-CD3 Antibody Treatment Reduces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice. Journal of the American Heart Association, 120, 1996-2005.